Amneal Pharmaceuticals (AMRX) Net Income (2017 - 2026)
Amneal Pharmaceuticals (AMRX) reported Net Income of $69.61 million for Q2 2026, up 95.5% from $35.61 million a year earlier but down 10.8% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Net Income (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Amneal Pharmaceuticals' Net Income came in at $215.32 million, up 320.2% year-over-year; for FY2025, it came in at $127.93 million.
- Net Income has a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- By year, Net Income came in at -$73.88 million in FY2024, -$48.72 million in FY2023, -$254.79 million in FY2022 and $20.17 million in FY2021 (-70.6%).
- Five-year quarterly Net Income spans a low of -$240.08 million in Q2 2022 and a high of $78 million in Q1 2026.
- Year over year, Net Income gained in four of the last five quarters, with growth averaging 85.1%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $78 million (Q1 2026), $49.57 million (Q4 2025) and $18.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Amneal Pharmaceuticals | 6.48 Bn | 5.76 Bn | 334.51 Mn | 69.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.61 Mn |
| Mar 31, 2026 | 78.00 Mn |
| Dec 31, 2025 | 49.57 Mn |
| Sep 30, 2025 | 18.13 Mn |
| Jun 30, 2025 | 35.61 Mn |
| Mar 31, 2025 | 24.62 Mn |
| Dec 31, 2024 | -20.74 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 16.79 Mn |
| Mar 31, 2024 | -81.68 Mn |
| Dec 31, 2023 | -93.34 Mn |
| Sep 30, 2023 | 25.03 Mn |
| Jun 30, 2023 | 29.68 Mn |
| Mar 31, 2023 | -10.09 Mn |
| Dec 31, 2022 | -5.86 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | -240.08 Mn |
| Mar 31, 2022 | -6.46 Mn |
| Dec 31, 2021 | -20.46 Mn |
| Sep 30, 2021 | -6.09 Mn |
API Access
Amneal Pharmaceuticals Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();